癌症相关的静脉血栓栓塞性疾病,版本2.2024,NCCN瘤学临床实践指南
Michael B Streiff1, Bjorn Holmstrom2, Dana Angelini3
1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Journal of the National Comprehensive Cancer Network : JNCCN
|September 5, 2024
概括
在NCCN指南中提供了预防,诊断和治疗癌症患者静脉血栓塞栓症 (VTE) 的策略. 这些指导方针涉及对各种癌症亚型的VTE评估和治疗选择.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 心脏病学 心脏病学
背景情况:
- 静脉血栓栓塞 (VTE) 是成年癌症患者经常发生的严重并发症.
- 在癌症中有效管理VTE需要采用多学科的方法.
研究的目的:
- 提出NCCN关于管理癌症相关的VTE的指导方针.
- 在成人癌症患者中概述VTE预防,诊断和治疗的策略.
主要方法:
- 由一个多学科的NCCN小组制定指导方针.
- 审查当前证据和有关癌症相关的VTE的专家共识.
主要成果:
- 这些指导方针为评估和治疗与癌症相关的各种VTE亚型提供了一个框架.
- 具体建议涵盖预防,诊断和治疗策略.
结论:
- 遵守NCCN指南可以优化癌症患者的VTE护理.
- 跨学科的合作对于管理VTE在这个人群中至关重要.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Standards of Care II
638
Nurses bear specific legal responsibilities under several federal statutes, including:
638
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Standards of Care I
670
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
670
Overview of Systemic Veins
446
Systemic veins are crucial blood vessels that return deoxygenated blood from various body tissues back to the heart. There are three systemic veins that return deoxygenated blood to the heart, they are as follows.
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
446


